Brasada Capital Management, LP Abb Vie Inc. Transaction History

Brasada Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$85.91 - $100.83 $859,100 - $1.01 Million	-10,000 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $293,480 - $392,720	4,000 Added 66.67%	10,000 $982,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $387,000 - $586,740	6,000 New	6,000 $457,000
Q4 2018 Feb 05, 2019	SELL	$77.85 - $96.01 $11,443 - $14,113	-147 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$88.91 - $98.84 $13,069 - $14,529	147 New	147 $14,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Brasada Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Brasada Capital Management, LP with notifications on news.